Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Limited utility of routine surveillance MRI following chemoradiation for advanced-stage oropharynx carcinoma.

Kangelaris GT, Yom SS, Huang K, Wang SJ.

Int J Otolaryngol. 2010;2010. pii: 904297. doi: 10.1155/2010/904297. Epub 2010 Aug 31.

2.

Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.

Yom SS, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS, Rosenthal DI.

Am J Clin Oncol. 2005 Aug;28(4):385-92.

PMID:
16062081
3.

Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.

Meads C, Auguste P, Davenport C, MaƂysiak S, Sundar S, Kowalska M, Zapalska A, Guest P, Thangaratinam S, Martin-Hirsch P, Borowiack E, Barton P, Roberts T, Khan K.

Health Technol Assess. 2013 Mar;17(12):1-323. doi: 10.3310/hta17120. Review.

4.

The advantages and drawbacks of routine magnetic resonance imaging for long-term post-treatment locoregional surveillance of oral cavity squamous cell carcinoma.

Al-Shwaiheen FA, Wang SJ, Uzelac A, Yom SS, Ryan WR.

Am J Otolaryngol. 2015 May-Jun;36(3):415-23. doi: 10.1016/j.amjoto.2015.01.024. Epub 2015 Feb 3.

PMID:
25697087
5.

The Limitations of Routine Magnetic Resonance Imaging for Long-Term Post-Treatment Locoregional Surveillance of Salivary Carcinoma.

Hemmat SM, Wang SJ, Uzelac A, Yom SS, Ryan WR.

ORL J Otorhinolaryngol Relat Spec. 2015;77(3):132-40. doi: 10.1159/000381027. Epub 2015 May 27.

PMID:
26022374
6.

Clinical Impact of Frequent Surveillance Imaging in the First Year Following Chemoradiation for Locally Advanced Non-small-cell Lung Cancer.

Ho QA, Harandi NK, Daly ME.

Clin Lung Cancer. 2016 Nov 21. pii: S1525-7304(16)30364-3. doi: 10.1016/j.cllc.2016.11.010. [Epub ahead of print]

PMID:
28007410
7.

Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.

Cripps C, Winquist E, Devries MC, Stys-Norman D, Gilbert R; Head and Neck Cancer Disease Site Group..

Curr Oncol. 2010 Jun;17(3):37-48.

8.

18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.

Krabbe CA, Pruim J, Dijkstra PU, Balink H, van der Laan BF, de Visscher JG, Roodenburg JL.

J Nucl Med. 2009 Dec;50(12):1940-7. doi: 10.2967/jnumed.109.065300. Epub 2009 Nov 12.

9.

Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?

Schreiner W, Dudek W, Lettmaier S, Fietkau R, Sirbu H.

J Cardiothorac Surg. 2016 Jan 19;11:9. doi: 10.1186/s13019-016-0396-0.

10.

Surgical salvage of cancer of the oropharynx after chemoradiation.

Bumpous JM.

Curr Oncol Rep. 2009 Mar;11(2):151-5. Review.

PMID:
19216847
11.

Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance.

Agrawal A, Hammond TH, Young GS, Avon AL, Ozer E, Schuller DE.

Laryngoscope. 2009 Nov;119(11):2135-40. doi: 10.1002/lary.20527.

PMID:
19507214
12.

Management of oropharyngeal cancer: a cross-sectional review of institutional practice at a large Canadian referral centre.

Wilson L, Enepekides D, Higgins K.

J Otolaryngol Head Neck Surg. 2014 Jun 24;43:19. doi: 10.1186/1916-0216-43-19.

13.

Squamous cell carcinoma of the oropharynx: single-institution outcome analysis of patients treated with concurrent chemoradiotherapy.

Yasumatsu R, Nakashima T, Komune S.

J Laryngol Otol. 2015 Mar;129 Suppl 2:S77-82. doi: 10.1017/S0022215114002448.

PMID:
25706168
14.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM)..

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
15.

The role of surveillance magnetic resonance imaging (MRI) scanning in detecting recurrent brain tumors in asymptomatic children.

Korones DN, Butterfield R, Meyers SP, Constine LS.

J Neurooncol. 2001 May;53(1):33-8.

PMID:
11678428
16.

Response measurement after intraarterial chemoradiation in advanced head and neck carcinoma: magnetic resonance imaging and evaluation under general anesthesia?

van den Broek GB, Rasch CR, Pameijer FA, Peter E, van den Brekel MW, Balm AJ.

Cancer. 2006 Apr 15;106(8):1722-9.

17.

Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.

Sandulache VC, Ow TJ, Daram SP, Hamilton J, Skinner H, Bell D, Rosenthal DI, Beadle BM, Ang KK, Kies MS, Johnson FM, El-Naggar AK, Myers JN.

Head Neck. 2013 Oct;35(10):1454-60. doi: 10.1002/hed.23173. Epub 2012 Sep 28.

PMID:
23018868
18.

Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.

Ng SH, Lin CY, Chan SC, Lin YC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Chang CJ, Wang JJ.

PLoS One. 2014 Dec 22;9(12):e115933. doi: 10.1371/journal.pone.0115933. eCollection 2014.

19.

Prognostic significance of hyoid bone invasion in advanced base of tongue carcinoma treated by chemoradiation.

Heaton CM, Al-Shwaiheen F, Liu CS, Yom SS, Ryan WR.

Clin Otolaryngol. 2015 Jun;40(3):260-5. doi: 10.1111/coa.12367.

PMID:
25641627
20.

Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.

Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G.

Nucl Med Commun. 2012 Jun;33(6):591-6. doi: 10.1097/MNM.0b013e3283516716.

PMID:
22334135

Supplemental Content

Support Center